Hepatocellular Carcinoma Clinical Trials in Taipei
16 recruitingTaipei, Taiwan
Showing 1–16 of 16 trials
Recruiting
Phase 1
A Study of ZW251 in Participants With Advanced Solid Tumors
Hepatocellular Carcinoma
Zymeworks BC Inc.100 enrolled20 locationsNCT07164313
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb129 enrolled45 locationsNCT07291076
Recruiting
Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Biliary Tract CancerHepatocellular Carcinoma
AstraZeneca294 enrolled60 locationsNCT05775159
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 2
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
Hepatocellular CarcinomaAdvanced Cancer
TaiRx, Inc.95 enrolled5 locationsNCT05257590
Recruiting
Phase 1
A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Hepatocellular Carcinoma
Myeloid Therapeutics70 enrolled9 locationsNCT06478693
Recruiting
Phase 1Phase 2
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Hepatocellular CarcinomaMetastatic Liver CancerLiver Cancer, Adult+1 more
Eureka Therapeutics Inc.20 enrolled7 locationsNCT04864054
Recruiting
Phase 1Phase 2
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
AstraZeneca304 enrolled20 locationsNCT06795022
Recruiting
Phase 2
Hepatic Arterial Infusion Chemotherapy With Lipiodol Embolization in Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
National Taiwan University Hospital24 enrolled1 locationNCT06632717
Recruiting
Phase 1
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Solid TumorsMetastatic Hepatocellular CarcinomaAdvanced Solid Tumors+11 more
Tyra Biosciences, Inc100 enrolled16 locationsNCT06915753
Recruiting
Phase 2
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Locally Advanced Hepatocellular Carcinoma
National Cancer Centre, Singapore100 enrolled14 locationsNCT05377034
Recruiting
Phase 2Phase 3
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
AbbVie660 enrolled37 locationsNCT06109272
Recruiting
Early Phase 1
Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)
Hepatocellular Carcinoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center43 enrolled4 locationsNCT04601428
Recruiting
Phase 2
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Hepatocellular Carcinoma
Lukas Biomedical Inc.95 enrolled13 locationsNCT05304481
Recruiting
Phase 4
Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC
Hepatocellular Carcinoma (HCC)Esophageal Varices
Taipei Veterans General Hospital, Taiwan120 enrolled1 locationNCT06594744
Recruiting
Phase 1Phase 2
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma
Hepatocellular Carcinoma
T-ACE Medical Co., Ltd90 enrolled4 locationsNCT05435014